Mechanistic Correlates of Clinical Responses to Omalizumab in the Setting of Oral Immunotherapy for Milk Allergy

Omalizumab distinctly altered IgE-dependent basophil activation but not Treg development during OIT. Baseline biomarkers may identify subjects likely to experience the greatest benefit from this adjunctive therapy in terms of both safety and efficacy.

http://ift.tt/2pgsgQZ